Thomas (“Tommy”) Miller, Esq., is Senior Counsel and Life Science Lead at Nixon Gwilt Law and is licensed in Virginia, Washington, D.C., and Maryland. Tommy has supported innovation and served clients in the healthcare and life science industries for over 10 years.
Rockville, Maryland’s Autonomous Therapeutics (Autonomous) is a rapidly expanding biotech developing the next generation of antivirals and therapeutics.
Lisa Tibbetts received a Master’s degree in Biotechnology from Georgetown University’s Department of Microbiology. She did her thesis in Usagi data mapping, pharmacovigilance, and artificial intelligence. She is also a graduate of Columbia University, Northwestern University, and Thomas Jefferson High School for Science and Technology and has worked in oncology, neurology, and most recently, satellite engineering.
Deborah Hemingway, Ph.D. named CEO of Maryland Development Center (MDC)
Personalized and regenerative medicines are promising but they are complex to develop and require highly-flexible advanced manufacturing techniques that are still too manually intensive and costly.
Ben Woodard is a Business Development Partner with ABIO and a recent retiree of the University of Maryland, where he was the Executive Director of the Biotech Research Program (BREP) for over a decade.
Mark Nardone is Director and Co-Founder of Bio-Trac®, a biotechnology training program that has served the scientific community for over 37 years, providing hands-on training workshops, designed by active researchers for research scientists, that focus on the latest relevant techniques that are necessary for laboratory research.
In 2020 we introduced a new series titled “5 Questions With…” in an effort to spotlight individuals from across the BioHealth Capital Region and beyond. Providing this platform has allowed us to help share the stories of industry peers and show that there isn’t a single “right” way to becoming an industry success.
Ian is an industrial microbiologist and fermentation scientist specializing in process optimization and upstream modification of cell culture parameters for increased yield, viability, and productivity. Experienced with a variety of fermentation technologies, including hollow-fiber bioreactor systems, industrial stirred-tanks, and shake-flasks, Ian is excited to lend his background in cell culture to the SBI team.
Tia Lyles-Williams, the founder & CEO of LucasPye BIO (LPB) and HelaPlex, is on a mission to lower development and manufacturing costs for emerging life science companies while bringing greater diversity to the life science industry.